Evidence shows its involvement in promoting mammary tumor growth and metastasis in mice as well as its activation in hepatocellular carcinoma under hypoxic conditions, both through BCL9/BCL9L and Wnt pathway activation [73,74]. Here, BCL9 is linked to breast cancer.